Your session is about to expire
← Back to Search
CGM-Assisted Diabetes Management for Older Adults with Mild Cognitive Impairment (CP-CGMH Trial)
CP-CGMH Trial Summary
This trial will provide a CGM device and app to older adults with T2D-MCI and their care partners to help with diabetes self-management. Interviews will evaluate the effectiveness of the app.
CP-CGMH Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCP-CGMH Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CP-CGMH Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does the trial include participants who are aged fifty or older?
"As per the trial's eligibility rules, senior citizens aged 65-100 may take part in this clinical study."
Is there an opportunity to join this experiment?
"This clinical trial seeks 20 participants between the ages of 65 and 100, all afflicted with type 2 diabetes mellitus. Additionally, enrollees must have a Montreal Cognitive Assessment score ranging from 19-25; possess knowledge of English language; have been living with T2D-MCI for at least one year; be willing to use CGM technology; as well as having an accompanying care partner (e.g., family member or close friend)."
Has the Food and Drug Administration given their approval for CP-CGMH?
"Our team at Power assessed the safety of CP-CGMH to be a 1, as this is an initial phase trial with limited data supporting both efficacy and security."
Are there any openings remaining for prospective participants in this research endeavor?
"Confirmation from clinicaltrials.gov reflects that this particular trial is no longer accepting participants, with the initial posting occurring on January 1st 2023 and its last amendment dating back to October 27th 2022. Nevertheless, there are 1847 trials currently seeking enrolment."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger